Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Milnacipran price, strengths & recalls

Generic of Savella

Pharmacies pay $81.81 for 30 tablets of Milnacipran 100 mg tablet this week, and from $36.45 to $84.90 across its 4 priced strengths and forms. 4 manufacturers make it. Its official label last changed on September 16, 2026.

Generic
Pharmacies pay$81.81for 30 tablets of 100 mg tablet-3.3% in 4 weeks
Fair cash price
$104.58
Strengths
4
Makers
4
Updated
Nov 11

Milnacipran price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
12.5 mg tablet$1.22$36.45 / 30 tablets+55.3%
25 mg tablet$2.38$71.52 / 30 tablets-5.6%
50 mg tablet$2.83$84.90 / 30 tablets+1.0%
100 mg tablet$2.73$81.81 / 30 tablets-3.3%

The lowest cost per tablet is 12.5 mg tablet at $1.22. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Brand names of milnacipran

A brand and its generic share the active ingredient; the generic is almost always far cheaper.

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for milnacipran? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedSeptember 16, 2026
Version1
EffectiveJan 31, 2026
Read the label

These highlights do not include all the information needed to use MILNACIPRAN HYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for MILNACIPRAN HYDROCHLORIDE TABLETS. MILNACIPRAN HYDROCHLORIDE tablets, for oral use Initial U.S. Approval: 2009

This drug has a boxed warning

BOXED WARNING

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS

Milnacipran hydrochloride tablets are selective serotonin and norepinephrine reuptake inhibitor (SNRI), similar to some drugs used for the treatment of depression and other psychiatric disorders. Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of major depressive disorder (MDD) and other psychiatric disorders. Anyone considering the use of such drugs in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on milnacipran hydrochloride tablets should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber. Milnacipran hydrochloride tablets are not approved for use in the treatment of major depressive disorder. Milnacipran hydrochloride tablets are not approved for use in pediatric patients [see Indications and Usage (1), Warnings and Precautions (5.1), Use in Specific Populations (8.4)].

WARNING: SUICIDALITY AND ANTIDEPRESSANT DRUGS

See full prescribing information for complete boxed warning.• Increased risk of suicidal ideation, thinking, and behavior in children, adolescents, and young adults taking antidepressants for major depressive disorder (MDD) and other psychiatric disorders (5.1).

• Milnacipran hydrochloride tablets are not approved for use in pediatric patients (1, 8.4).

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA022256 · Abbvie
First approved
January 14, 2009 (17 years ago)
Latest approved change
September 10, 2025
Approved label
PDF, Sep 11, 2025
Generic makers
3 approved generic applications on the market
Last patent listed
September 19, 2029

Milnacipran questions

How much does milnacipran cost without insurance?

Pharmacies pay about $81.81 for 30 tablets of milnacipran 100 mg tablet ($2.73 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $104.58. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

What is the brand name of milnacipran?

Milnacipran is sold as Savella. The generic has the same active ingredient and usually costs far less.

Is milnacipran in shortage?

No shortage is reported for milnacipran right now. We check the national shortage list every day.

Has milnacipran been recalled?

No recalls are on record for milnacipran.

When did the milnacipran label last change?

The official label was last updated on September 16, 2026 (version 1). See what changed.

Talk about milnacipran

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.